Intech Investment Management LLC Sells 28,449 Shares of DaVita Inc. (NYSE:DVA)

Intech Investment Management LLC lessened its stake in DaVita Inc. (NYSE:DVA) by 48.8% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 29,801 shares of the company’s stock after selling 28,449 shares during the quarter. Intech Investment Management LLC’s holdings in DaVita were worth $4,130,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DVA. 8 Knots Management LLC bought a new stake in DaVita in the fourth quarter valued at approximately $89,504,000. Doma Perpetual Capital Management LLC bought a new stake in shares of DaVita in the 4th quarter valued at $53,076,000. Harvard Management Co. Inc. acquired a new stake in DaVita during the 2nd quarter worth $55,115,000. Norges Bank bought a new position in DaVita during the fourth quarter worth about $36,626,000. Finally, Allianz Asset Management GmbH grew its stake in DaVita by 63.9% in the fourth quarter. Allianz Asset Management GmbH now owns 548,642 shares of the company’s stock valued at $57,476,000 after acquiring an additional 213,992 shares during the period. Institutional investors own 90.12% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on DVA. UBS Group raised their price target on DaVita from $169.00 to $175.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. StockNews.com lowered shares of DaVita from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 8th. Bank of America increased their price objective on shares of DaVita from $139.00 to $145.00 and gave the stock an “underperform” rating in a research report on Wednesday, August 7th. Truist Financial boosted their price objective on shares of DaVita from $150.00 to $165.00 and gave the company a “hold” rating in a research report on Tuesday, August 20th. Finally, TD Cowen increased their target price on DaVita from $139.00 to $150.00 and gave the stock a “hold” rating in a report on Wednesday, July 24th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, DaVita currently has a consensus rating of “Hold” and an average target price of $157.00.

DaVita Price Performance

NYSE DVA opened at $164.00 on Friday. DaVita Inc. has a 12-month low of $71.51 and a 12-month high of $166.04. The firm’s 50 day moving average is $147.64 and its 200-day moving average is $141.16. The company has a market capitalization of $14.38 billion, a PE ratio of 18.64, a price-to-earnings-growth ratio of 0.95 and a beta of 0.87. The company has a quick ratio of 1.12, a current ratio of 1.16 and a debt-to-equity ratio of 9.94.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $2.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.47 by $0.12. The firm had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.15 billion. DaVita had a net margin of 6.86% and a return on equity of 77.00%. The company’s revenue was up 6.2% compared to the same quarter last year. During the same period in the previous year, the business earned $2.08 EPS. Equities research analysts anticipate that DaVita Inc. will post 9.99 earnings per share for the current fiscal year.

Insider Activity at DaVita

In other DaVita news, insider Kathleen Alyce Waters sold 7,857 shares of the business’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the transaction, the insider now owns 83,011 shares of the company’s stock, valued at approximately $12,137,038.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, insider Kathleen Alyce Waters sold 7,857 shares of the business’s stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $146.21, for a total transaction of $1,148,771.97. Following the transaction, the insider now directly owns 83,011 shares in the company, valued at $12,137,038.31. The sale was disclosed in a filing with the SEC, which is available through this link. Also, COO Michael David Staffieri sold 9,539 shares of the company’s stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $150.03, for a total transaction of $1,431,136.17. Following the sale, the chief operating officer now directly owns 241,945 shares in the company, valued at $36,299,008.35. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 173,482 shares of company stock valued at $27,387,069. Insiders own 2.00% of the company’s stock.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.